SCHEMBL20083990

SCHEMBL20083990

Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N(CCO)C3CC3)c2)cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ ALDH1A1 P00352 5/20 0.48
▸ MAPT P10636 4/20 0.48
▸ TSHR P16473 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ NPC1 O15118 4/20 0.48
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ POLB P06746 2/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ ADRB2 P07550 1/20 0.46
▸ HTR2B P41595 1/20 0.45
▸ SIRT2 Q8IXJ6 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15276910 0.91 HTR2B (0.56) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL21844860 0.90 SMN1; SMN2 (0.58) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL15276906 0.86 SIRT2 (0.52) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL15276904 0.85 MAPT (0.52) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL19157167 0.84 LMNA (0.54) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL15276907 0.84 SLC6A9 (0.46) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL15276908 0.83 ALDH1A1 (0.44) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL15276909 0.83 RAB9A (0.50) LMNARAB9AALDH1A1MAPTTSHR
SCHEMBL21844861 0.79 PSEN1 (0.38) ALDH1A1MAPTGAASMN1; SMN2KMT2A
SCHEMBL20084043 0.77 SMN1; SMN2 (0.47) LMNARAB9AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
EP-3312160-A1 HEPATITIS B ANTIVIRAL AGENTS Novira Therapeutics Inc. (US) 2018-04-25 — — EP disclosed
Send feedback